Symbiotec Pharmalab IPO GMP Today
ListedUpdated 1 September 2026, 5:30 PM IST· Mainboard· Listing 1 Sept 2026
Symbiotec Pharmalab IPO opens on 24 August 2026. Symbiotec Pharmalab IPO GMP is Rs 185.00 today. Listing price estimate is Rs 1,173.00 (issue price Rs 988.00). Listing gain estimate: 18.72%.
Symbiotec Pharmalab IPO GMP Day Wise
Daily grey market premium, estimated listing price, and profit per lot
GMP for Symbiotec Pharmalab IPO started at Rs 220 on 19 August 2026 and stood at Rs 185 on 1 September 2026. The sharpest single-day jump was from Rs 220 on 19 Aug 2026 to Rs 300 on 20 Aug 2026. The downward trend suggests grey market participants are lowering expectations. Watch whether subscription numbers support or contradict this move.
| Date | Issue Price | GMP | Listing Price | Est. Profit |
|---|---|---|---|---|
| 1 Sept 2026Today | Rs 988.00 | Rs 185.00 | Rs 1,173.00 (+18.72%) | Rs 2,775.00 |
| 31 Aug 2026 | Rs 988.00 | Rs 185.00 | Rs 1,173.00 (+18.72%) | Rs 2,775.00 |
| 30 Aug 2026 | Rs 988.00 | Rs 240.00 | Rs 1,228.00 (+24.29%) | Rs 3,600.00 |
| 29 Aug 2026 | Rs 988.00 | Rs 240.00 | Rs 1,228.00 (+24.29%) | Rs 3,600.00 |
| 28 Aug 2026 | Rs 988.00 | Rs 265.00 | Rs 1,253.00 (+26.82%) | Rs 3,975.00 |
| 27 Aug 2026 | Rs 988.00 | Rs 270.00 | Rs 1,258.00 (+27.33%) | Rs 4,050.00 |
| 26 Aug 2026 | Rs 988.00 | Rs 285.00 | Rs 1,273.00 (+28.85%) | Rs 4,275.00 |
| 25 Aug 2026 | Rs 988.00 | Rs 352.00 | Rs 1,340.00 (+35.63%) | Rs 5,280.00 |
| 24 Aug 2026 | Rs 988.00 | Rs 335.00 | Rs 1,323.00 (+33.91%) | Rs 5,025.00 |
| 23 Aug 2026 | Rs 988.00 | Rs 409.00 | Rs 1,397.00 (+41.40%) | Rs 6,135.00 |
| 22 Aug 2026 | Rs 988.00 | Rs 410.00 | Rs 1,398.00 (+41.50%) | Rs 6,150.00 |
| 21 Aug 2026 | Rs 988.00 | Rs 345.00 | Rs 1,333.00 (+34.92%) | Rs 5,175.00 |
| 20 Aug 2026 | Rs 988.00 | Rs 300.00 | Rs 1,288.00 (+30.36%) | Rs 4,500.00 |
| 19 Aug 2026 | Rs 988.00 | Rs 220.00 | Rs 1,208.00 (+22.27%) | Rs 3,300.00 |
Symbiotec Pharmalab IPO Listing Price
Estimated from today’s GMP
Based on today's GMP, Symbiotec Pharmalab IPO listing price estimate is Rs 1,173.00 per share (issue price Rs 988.00 + GMP Rs 185.00).
Actual listing price will be known on 1 September 2026 when the stock lists on NSE/BSE.
Symbiotec Pharmalab IPO Listing Gain
Estimated profit per lot from grey market premium
Lot size: 15 shares
GMP today: Rs 185.00
Estimated listing gain per lot: Rs 185.00 × 15 = Rs 2,775.00
GMP at roughly 18.7% suggests solid informal demand. The grey market expects the stock to list noticeably above the issue price.
GMP has trended lower. Read this together with subscription data before applying.
GMP is unofficial. Listing gain can differ on listing day.
Symbiotec Pharmalab IPO Subscription Status
GMP and subscription numbers often move together. When institutional and HNI demand is strong, grey market participants usually price in a higher premium. Current overall subscription for Symbiotec Pharmalab IPO is 75.06x. Compare this with the GMP trend to see if demand aligns. The GMP move around 20 Aug 2026 may reflect how the market reacted once the subscription window activity picked up after 24 Aug 2026.
See live figures on the Symbiotec Pharmalab IPO Subscription Status page.
Symbiotec Pharmalab IPO Details
| Field | Value |
|---|---|
| Price Band | ₹938.0 - ₹988.0 |
| Issue Size | ₹1,757.00 Cr |
| Lot Size | 15 shares |
| IPO Type | Mainboard |
| Open Date | 24 Aug 2026 |
| Close Date | 27 Aug 2026 |
| Listing Date | 1 Sept 2026 |
| Subscription | 75.06x |
Symbiotec Pharmalab IPO full details (financials, peers, review).
About Symbiotec Pharmalab IPO
Symbiotec Pharmalab Limited (incorporated in 2002) is an established research-driven pharmaceutical and biotechnology company specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), particularly corticosteroids and steroidal-hormone APIs, alongside contract development and manufacturing (CDMO) services and complex injectables. The company operates industrial-scale manufacturing facilities at Rau and Pithampur SEZ in Madhya Pradesh with US FDA, EU-GMP, and WHO-GMP approvals, alongside newly commissioned biomanufacturing facilities in Ujjain and dedicated complex injectables facilities in Mhow. As of March 31, 2026, Symbiotec served over 200 customers across more than 40 countries, holding 43 US FDA Drug Master Files (DMFs) and 23 European Certificates of Suitability (CEPs).
Symbiotec Pharmalab IPO GMP FAQs
What is Symbiotec Pharmalab IPO GMP today?
Symbiotec Pharmalab IPO GMP is ₹185 as of 9 September 2026, 5:47 PM IST. At issue price ₹988, that is +18.72% expected listing gain in the grey market.
What is Symbiotec Pharmalab IPO grey market premium (GMP)?
The grey market premium (GMP) for Symbiotec Pharmalab IPO is ₹185 today. GMP is the unofficial premium traders pay above the issue price of ₹988 before listing on NSE/BSE.
What is Symbiotec Pharmalab IPO expected returns?
Symbiotec Pharmalab IPO expected returns based on today's GMP are +18.72% over the issue price of ₹988. Estimated listing price is ₹1,173 per share. Actual listing gain on 1 September 2026 may differ.
What is the estimated listing price of Symbiotec Pharmalab IPO?
Based on today's GMP, Symbiotec Pharmalab IPO estimated listing price is ₹1,173 per share (issue price ₹988 + GMP ₹185). The actual listing price will be set on 1 September 2026 when trading starts.
What is the expected profit per lot in Symbiotec Pharmalab IPO?
At GMP of ₹185 and lot size of 15 shares, estimated grey market profit is ₹2,775 (1 lot × 15 shares × ₹185). This is unofficial and not guaranteed on listing day.
Will Symbiotec Pharmalab IPO list at GMP price?
Symbiotec Pharmalab IPO may list around ₹1,173 based on current GMP of ₹185, but listing at exact grey market price is not guaranteed. GMP is unofficial. On 1 September 2026, the opening price depends on market sentiment, final subscription, and index levels.
What is Symbiotec Pharmalab IPO issue price and lot size?
Symbiotec Pharmalab IPO issue price is ₹988 per share (price band ₹938.0 - ₹988.0). Lot size is 15 shares. Minimum application is 1 lot.
When is Symbiotec Pharmalab IPO listing date?
Symbiotec Pharmalab IPO is expected to list on 1 September 2026 on NSE and BSE. GMP can still move until listing day.
What is Symbiotec Pharmalab IPO GMP high and low?
Symbiotec Pharmalab IPO GMP made a high of ₹410 on 22 Aug 2026 and a low of ₹185 on 1 Sept 2026 in tracked grey market data.
Can Symbiotec Pharmalab IPO GMP change after subscription closes?
Yes. Symbiotec Pharmalab IPO closed on 27 August 2026. GMP often moves until listing (1 September 2026) based on allotment buzz, market mood, and news. Keep this page handy for the latest figure.
What is Symbiotec Pharmalab IPO subscription status?
Live category-wise subscription for Symbiotec Pharmalab IPO is on the Symbiotec Pharmalab IPO Subscription Status page on IPOwiz, including QIB, NII, and retail figures.
How to check Symbiotec Pharmalab IPO allotment status?
You can check Symbiotec Pharmalab IPO allotment with your PAN on the Symbiotec Pharmalab IPO Allotment Status page, the registrar site, BSE, or the IPOwiz App.
Sources
We match Symbiotec Pharmalab IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- IPO RegistrarRegistrar details are on the allotment page for this IPO
Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews GMP figures before they go live.